サマリー

この調査によると、世界の脳梗塞治療市場規模は2030年までに100万米ドルに達する。
脳梗塞は慢性的で生命を脅かす疾患である。脳梗塞は虚血性脳卒中の最も重要なタイプの一つであり、血管の閉塞や血栓の発生により血液が脳に流入する。脳梗塞は脳出血とは異なることを強調することが重要である。脳梗塞は突然発症するため、死亡する可能性が高い。
本レポートでは、脳梗塞治療市場の包括的な概要、市場シェア、成長機会を、製品タイプ、用途、主要プレイヤー、主要地域、国別に紹介します。
製品タイプ別セグメンテーション
前方循環部分梗塞（PACI）
全前方循環梗塞（TACI）
後循環梗塞（POCI）
用途別セグメント
病院
クリニック
医療研究機関
本レポートはまた、市場を地域別に分割しています：
米国
中国
ヨーロッパ
その他の地域
日本
韓国
東南アジア
その他の地域
本レポートはまた、市場の競争環境とそれに対応する市場の主要プレイヤーの詳細な分析も提示しています。本レポートでカバーする主要企業
第一三共
ジョンソン＆ジョンソン
アプロジェン
バクスター
大塚製薬
三菱ケミカルホールディングス
ノルマルク
武田薬品工業
サノフィ
ブリストル・マイヤーズ スクイブ
カニオン

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cerebral Infarction Therapy Market Size 2024-2030
2.1.2 Cerebral Infarction Therapy Market Size CAGR by Region
2.2 Cerebral Infarction Therapy Segment by Type
2.2.1 Partial Anterior Circulation Infarct (PACI)
2.2.2 Total Anterior Circulation Infarct (TACI)
2.2.3 Posterior Circulation Infarct (POCI)
2.3 Cerebral Infarction Therapy Market Size by Type
2.3.1 Global Cerebral Infarction Therapy Market Size Market Share by Type (2024-2030)
2.3.2 Global Cerebral Infarction Therapy Market Size Growth Rate by Type (2024-2030)
2.4 Cerebral Infarction Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Medical Research Organization
2.5 Cerebral Infarction Therapy Market Size by Application
2.5.1 Global Cerebral Infarction Therapy Market Size Market Share by Application (2024-2030)
2.5.2 Global Cerebral Infarction Therapy Market Size Growth Rate by Application (2024-2030)
3 Cerebral Infarction Therapy Key Players
3.1 Date of Key Players Enter into Cerebral Infarction Therapy
3.2 Key Players Cerebral Infarction Therapy Product Offered
3.3 Key Players Cerebral Infarction Therapy Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Cerebral Infarction Therapy Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Cerebral Infarction Therapy by Regions
4.1 Cerebral Infarction Therapy Market Size by Regions (2024-2030)
4.2 United States Cerebral Infarction Therapy Market Size Growth (2024-2030)
4.3 China Cerebral Infarction Therapy Market Size Growth (2024-2030)
4.4 Europe Cerebral Infarction Therapy Market Size Growth (2024-2030)
4.5 Rest of World Cerebral Infarction Therapy Market Size Growth (2024-2030)
5 United States
5.1 United States Cerebral Infarction Therapy Market Size by Type (2024-2030)
5.2 United States Cerebral Infarction Therapy Market Size by Application (2024-2030)
6 Europe
6.1 Europe Cerebral Infarction Therapy Market Size by Type (2024-2030)
6.2 Europe Cerebral Infarction Therapy Market Size by Application (2024-2030)
7 China
7.1 China Cerebral Infarction Therapy Market Size by Type (2024-2030)
7.2 China Cerebral Infarction Therapy Market Size by Application (2024-2030)
8 Rest of World
8.1 Rest of World Cerebral Infarction Therapy Market Size by Type (2024-2030)
8.2 Rest of World Cerebral Infarction Therapy Market Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Cerebral Infarction Therapy
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Daiichi Sankyo
11.1.1 Daiichi Sankyo Company Details
11.1.2 Daiichi Sankyo Cerebral Infarction Therapy Product Offered
11.1.3 Daiichi Sankyo Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.1.4 Daiichi Sankyo Main Business Overview
11.1.5 Daiichi Sankyo News
11.2 Johnson＆Johnson
11.2.1 Johnson＆Johnson Company Details
11.2.2 Johnson＆Johnson Cerebral Infarction Therapy Product Offered
11.2.3 Johnson＆Johnson Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.2.4 Johnson＆Johnson Main Business Overview
11.2.5 Johnson＆Johnson News
11.3 Aprogen
11.3.1 Aprogen Company Details
11.3.2 Aprogen Cerebral Infarction Therapy Product Offered
11.3.3 Aprogen Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.3.4 Aprogen Main Business Overview
11.3.5 Aprogen News
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Baxter Cerebral Infarction Therapy Product Offered
11.4.3 Baxter Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.4.4 Baxter Main Business Overview
11.4.5 Baxter News
11.5 Otsuka
11.5.1 Otsuka Company Details
11.5.2 Otsuka Cerebral Infarction Therapy Product Offered
11.5.3 Otsuka Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.5.4 Otsuka Main Business Overview
11.5.5 Otsuka News
11.6 Mitsubishi Chemical Holdings Corporation
11.6.1 Mitsubishi Chemical Holdings Corporation Company Details
11.6.2 Mitsubishi Chemical Holdings Corporation Cerebral Infarction Therapy Product Offered
11.6.3 Mitsubishi Chemical Holdings Corporation Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.6.4 Mitsubishi Chemical Holdings Corporation Main Business Overview
11.6.5 Mitsubishi Chemical Holdings Corporation News
11.7 Nordmark
11.7.1 Nordmark Company Details
11.7.2 Nordmark Cerebral Infarction Therapy Product Offered
11.7.3 Nordmark Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.7.4 Nordmark Main Business Overview
11.7.5 Nordmark News
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Cerebral Infarction Therapy Product Offered
11.8.3 Takeda Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda News
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Cerebral Infarction Therapy Product Offered
11.9.3 Sanofi Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi News
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Cerebral Infarction Therapy Product Offered
11.10.3 Bristol-Myers Squibb Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.10.4 Bristol-Myers Squibb Main Business Overview
11.10.5 Bristol-Myers Squibb News
11.11 Kanion Pharmaceutical
12 Research Findings and Conclusion